Does Mild Traumatic Brain Injury Increase the Risk for Dementia? A Systematic Review and Meta-Analysis

2020 ◽  
Vol 78 (2) ◽  
pp. 757-775
Author(s):  
Taylor M. Snowden ◽  
Anthony K. Hinde ◽  
Hannah M.O. Reid ◽  
Brian R. Christie

Background: Mild traumatic brain injury (mTBI) is a putative risk factor for dementia; however, despite having apparent face validity, the evidence supporting this hypothesis remains inconclusive. Understanding the role of mTBI as a risk factor is becoming increasingly important given the high prevalence of mTBI, and the increasing societal burden of dementia. Objective: Our objective was to use the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) format to determine if an association exists between mTBI and dementia and related factors, and to quantify the degree of risk. Methods: In this format, two authors conducted independent database searches of PubMed, PsycInfo, and CINAHL using three search blocks to find relevant papers published between 2000 and 2020. Relevant studies were selected using pre-defined inclusion/exclusion criteria, and bias scoring was performed independently by the two authors before a subset of studies was selected for meta-analysis. Twenty-one studies met the inclusion criteria for this systematic review. Results: The meta-analysis yielded a pooled odds ratio of 1.96 (95% CI 1.698–2.263), meaning individuals were 1.96 times more likely to be diagnosed with dementia if they had a prior mTBI. Most studies examining neuropsychiatric and neuroimaging correlates of dementia found subtle, persistent changes after mTBI. Conclusion: These results indicate that mTBI is a risk factor for the development of dementia and causes subtle changes in performance on neuropsychiatric testing and brain structure in some patients.

2010 ◽  
Vol 117 (2-3) ◽  
pp. 194-195
Author(s):  
Charlene Molloy ◽  
Ronan Conroy ◽  
Dearbhla Connor ◽  
David Cotter ◽  
Mary Cannon

CJEM ◽  
2017 ◽  
Vol 19 (S1) ◽  
pp. S60
Author(s):  
E. Mercier ◽  
P. Tardif ◽  
P. Cameron ◽  
B. Batomen Kuimi ◽  
M. Émond ◽  
...  

Introduction: Mild traumatic brain injury (mTBI) is a major cause of morbidity but there are no validated tools to help clinicians predict post-concussion symptoms. This systematic review and meta-analysis aimed to determine the prognostic value of S-100B protein to predict post-concussion symptoms following a mTBI in adults. Methods: The protocol of this systematic review was registered with the PROSPERO database (CRD42016032578). A search strategy was performed on seven databases (CINAHL, Cochrane CENTRAL, EMBASE, MEDLINE, Web of Knowledge, PyscBITE, PsycINFO) from their inception to October 2016. Studies evaluating the association between S-100B protein level and post-concussion symptoms assessed at least seven days after the mTBI were eligible. Individual patient data were requested. Studies eligibility assessment, data extraction and risk of bias assessment were performed independently by two researchers. Analyses were done following the meta-analysis using individual participant data or summary aggregate data guidelines from the Cochrane Methodology Review Group. Results: Outcomes were dichotomised as persistent (≥3 months) or early (≥7 days <3 months). Our search strategy yielded 23,298 citations of which 29 studies presenting between seven and 223 patients (n=2505) were included. Post-concussion syndrome (PCS) (16 studies), neuropsychological symptoms (9 studies) and health-related quality of life (4 studies) were the most frequently presented outcomes. The S-100B protein serum level of patients with no PCS was similar to that of patients experiencing persistent PCS (mean difference 0.00 [-0.05, 0.04]) or early PCS (mean difference 0.03 [-0.02, 0.08]). The odds of having persistent PCS (OR 0.56 (95% CI: 0.29-1.10) or early PCS (OR 1.67 (95% CI: 0.98-2.85) in patients with an elevated S-100B protein serum level was not significantly different from that of patients with normal values. No meta-analysis was performed for other outcomes than PCS due to heterogeneity and small samples. Studies’ overall risk of bias was considered moderate. Conclusion: Results suggest that the prognostic value of S-100B protein serum level to predict persistent and early post-concussion symptoms is limited. Variability in injury to S-100B protein sample time and outcomes assessed could potentially explain the lack of association and needs further evaluation.


2017 ◽  
Vol 34 (12) ◽  
pp. A862-A863
Author(s):  
Carl Marincowitz ◽  
Fiona Lecky ◽  
William Townend ◽  
Aditya Borakati ◽  
Trevor Sheldon

2018 ◽  
Vol 35 (4) ◽  
pp. 609-622 ◽  
Author(s):  
Eric Mercier ◽  
Pier-Alexandre Tardif ◽  
Peter A. Cameron ◽  
Brice Lionel Batomen Kuimi ◽  
Marcel Émond ◽  
...  

Brain Injury ◽  
2018 ◽  
Vol 32 (13-14) ◽  
pp. 1623-1636 ◽  
Author(s):  
Ben Bloom ◽  
Stephen Thomas ◽  
Jette Møller Ahrensberg ◽  
Rachel Weaver ◽  
Alex Fowler ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document